Skip to main content
TipRanks
Go Ultimate75% OFF

Crispr Therapeutics AG (1CG) Q4 2023 Earnings Report

22 Followers

DE:1CG Q4 2023 EPS Results

Actual EPS
EUR 1.00
Consensus EPS
EUR 0.06
Beat/Miss
Beat by +EUR 0.94
One Year Ago EPS
-EUR 1.29

DE:1CG Q4 2023 Revenue Results

Actual Revenue
EUR 183.50M
Expected Revenue
EUR 128.54M
Beat/Miss
Beat by +EUR 54.96M
YoY Revenue Growth
+3353333.33%

Earnings Announcement Details

Quarter
Q4 2023
Date
02/21/2024
Time
Before Open
Conference Call
Wednesday, February 21, 2024
DE:1CG Upcoming Earnings

Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:1CG Earnings History

DE:1CG earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 16, 20272026 (Q4)-1.06--1.25――
Nov 02, 20262026 (Q3)-0.95-1.05-1.071.71% (+0.02)
Aug 03, 20262026 (Q2)-1.09-0.86-2.1960.83% (+1.33)
May 04, 20262026 (Q1)-1.11-1.17-1.4418.99% (+0.27)
Feb 12, 20262025 (Q4)-1.06-1.25-0.4-211.36% (-0.85)
Nov 10, 20252025 (Q3)-1.15-1.07-0.92-15.84% (-0.15)
Aug 04, 20252025 (Q2)-1.28-2.19-1.36-61.07% (-0.83)
May 06, 20252025 (Q1)-1.13-1.44-1.3-10.49% (-0.14)
Feb 11, 20252024 (Q4)-1.10-0.401-140.00% (-1.40)
Nov 05, 20242024 (Q3)-1.28-0.92-1.2928.37% (+0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed